Robert W. Baird Has Lowered Expectations for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its target price dropped by investment analysts at Robert W. Baird from $1,375.00 to $1,310.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. Robert W. Baird’s target price indicates a potential upside of 3.89% from the stock’s previous close.

MTD has been the subject of several other reports. JPMorgan Chase & Co. raised their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Wells Fargo & Company began coverage on Mettler-Toledo International in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 target price on the stock. Evercore ISI increased their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Finally, Stifel Nicolaus lifted their price objective on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a “buy” rating in a research note on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $1,338.75.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,260.97 on Monday. The stock has a fifty day simple moving average of $1,394.23 and a two-hundred day simple moving average of $1,402.64. Mettler-Toledo International has a 52-week low of $1,015.29 and a 52-week high of $1,546.93. The firm has a market capitalization of $26.76 billion, a PE ratio of 33.70, a PEG ratio of 3.83 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 532.25% and a net margin of 21.15%. The company had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. On average, sell-side analysts forecast that Mettler-Toledo International will post 40.34 EPS for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In related news, insider Christian Magloth sold 1,000 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the sale, the insider now owns 734 shares in the company, valued at approximately $1,044,459.98. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Gateway Investment Advisers LLC bought a new position in Mettler-Toledo International during the 2nd quarter valued at about $685,000. Swedbank AB bought a new position in shares of Mettler-Toledo International during the first quarter valued at approximately $26,867,000. SG Americas Securities LLC raised its holdings in shares of Mettler-Toledo International by 501.6% in the first quarter. SG Americas Securities LLC now owns 2,954 shares of the medical instruments supplier’s stock worth $3,933,000 after buying an additional 2,463 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in shares of Mettler-Toledo International by 14.0% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock worth $1,860,000 after acquiring an additional 152 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC boosted its holdings in Mettler-Toledo International by 212.2% during the 2nd quarter. Linden Thomas Advisory Services LLC now owns 1,308 shares of the medical instruments supplier’s stock valued at $1,828,000 after acquiring an additional 889 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.